Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

2022; Massachusetts Medical Society; Volume: 386; Issue: 5 Linguagem: Inglês

10.1056/nejmoa2108330

ISSN

1533-4406

Autores

Vicky Makker, Nicoletta Colombo, Antonio Casado, Alessandro D. Santin, Émeline Colomba, David S. Miller, Keiichi Fujiwara, Sandro Pignata, Sally Baron‐Hay, Isabelle Ray‐Coquard, Ronnie Shapira‐Frommer, Kimio Ushijima, Jun Sakata, Kan Yonemori, Yong Man Kim, Eva Guerra, Ulus Ali Şanlı, Mary McCormack, Alan D. Smith, Stephen J. O’Keefe, Steven Bird, Lea Dutta, Robert Orlowski, Domenica Lorusso,

Tópico(s)

Endometriosis Research and Treatment

Resumo

Standard therapy for advanced endometrial cancer after failure of platinum-based chemotherapy remains unclear.

Referência(s)